AMERX Health Care Corporation

AMERX Health Care Corporation, founded in 1993, is a medical consumables manufacturer specializing in topical skin and wound care products. The company's primary product portfolio includes AMERIGEL® hydrogel wound dressings, HELIX3® bioactive collagen formulations, AMERX® comprehensive wound care kits and dressings, and EXTREMIT-EASE® compression garments. Products address acute and chronic wound management, post-operative care, and compression therapy across healthcare facilities and private practice settings. The company manufactures and distributes multiple wound dressing modalities including hydrogel, foam, bordered foam, calcium alginate, and collagen-based products. Collagen offerings span HELIX3-CP (powder), HELIX3-CM (matrix), and HELIX3-CG (gel) formulations. Complementary offerings include AMERIGEL Care Lotion, Barrier Lotion, Saline Wound Wash, and retention tape for wound management. EXTREMIT-EASE compression garments are offered in standard and night variants with matching garment liners. Curated 30-day wound care kits combine multiple products for standardized treatment protocols. AMERX operates a Turn-Key DME program enabling in-office product dispensing by physicians to enhance patient compliance, practice revenue, and practice efficiency. The company serves physicians, hospital systems, wound centers, and other healthcare facilities across the United States. Products are indicated for diabetic wounds, pressure injuries, surgical sites, and general acute and chronic wounds. The company emphasizes quality, proven clinical outcomes, and established relationships spanning over 30 years.